Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Pelage is recruiting for phase 2 trials, showing promise for treating bald regions. The discussion highlights its potential effectiveness based on its mechanism of action.

OP has been using 2.5mg minoxidil for 1.3 years and 1mg finasteride for 4 months with minimal hair growth results. OP reports persistent baby hairs with no significant change.

Dutasteride takes 1-3 months to affect scalp DHT levels, not just a week. The prostate absorbs Dutasteride faster than the scalp due to different vascular networks and enzyme densities.

The user has been using 1mg daily finasteride for 6 months and is unsure about its effectiveness, as they see no significant improvement. Other users suggest giving it more time and possibly combining it with oral minoxidil for better results.

The user started using minoxidil 10% in July 2024 and added 1 mg finasteride daily a month ago, experiencing initial shedding with both treatments but noticing some hair density improvement. They seek feedback on progress and advice on managing shedding, with suggestions including patience and possibly adding microneedling.

After 13 years on finasteride, OP is experiencing reduced effectiveness and has started taking 0.5 mg of dutasteride weekly, noticing nipple sensitivity as a side effect. OP plans to increase the dutasteride dosage and retest hormone levels, while others suggest adjusting the dosage or trying different forms of dutasteride.

Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

The user shared their 11-month progress using Rogaine 5% and dermastamping, noting significant hair density improvement around month 9. They plan to start finasteride soon, as suggested by others, to maintain results.

The user started finasteride and minoxidil in December, increased the dosage after a few months, and noticed improvements around months 6 to 8 despite initial shedding. They experienced no side effects from finasteride but had to adjust minoxidil due to palpitations.

Setipiprant and bimatoprost are being discussed as potential future treatments for hair loss. Some individuals have started testing setipiprant before FDA approval, but no progress updates are available yet.

A user shared their positive progress after 3.5 months of using finasteride and minoxidil for hair regrowth, noting increased hair density and new growth around the temples. They experienced minimal side effects and slight initial shedding, and emphasized the importance of consistency and patience with the treatment.

The user reported slight improvement in hairline using 1% Clascoterone cream over three months but found it too costly to continue. They expressed interest in trying a 5% concentration if it becomes available at a reasonable price.

The user experienced hair improvement after one year using 0.5 mg oral dutasteride, 5 mg oral minoxidil, and ketoconazole shampoo three times a week. They noticed progress after initial shedding and attribute changes to medication adjustments.

The user started using 0.5mg Dutasteride, switched to 10mg oral Minoxidil, and began micro-needling in February 2026, noticing slow but steady hair growth. Other users suggest using lower doses of Minoxidil and commend the visible progress.

The user is experiencing hair shedding after using minoxidil and is considering switching to dutasteride while planning to increase their oral minoxidil dose. They also use nicotine pouches, Vyvanse, and GHK-Cu, and have noticed thicker eyebrows and lashes from oral minoxidil.

The conversation is about the availability of gt20029 for hair loss treatment, indicating that it will not be available for purchase soon. No specific treatments were discussed.

The user has been using finasteride for three years and topical minoxidil, and while they feel they've lost some ground in the last 18 months, most responses suggest their hair looks the same or even fuller. The general consensus is that the treatments have maintained the hair well, with some users suggesting additional treatments like derma stamping or dutasteride for further improvement.

PP405 might take 3-4 years to be available, but some claim Everychem offers a similar product, though its effectiveness is debated. Users discuss the risks of using untested grey market products and the potential for adverse effects.

The conversation is about the availability of a 2% Pyrilutamide treatment by Kintor for hair loss. A user confirms that it is not available.

A user experienced continuous hair shedding for 13 months after starting finasteride, suspecting it might cause chronic telogen effluvium, and considered switching to dutasteride or stopping medication. Other users suggested that finasteride doesn't cause hair loss, recommending dutasteride for more aggressive hair loss, while some advised against stopping medication.

Hair cloning advancements are slow, with viable treatments expected around 2030-2035, but current methods are not yet suitable for transplantation. Finasteride is recommended as an effective treatment for hair loss, though it doesn't work for everyone.

A user plans a drug-free hair transplant while waiting for future treatments like stem cell therapies, which are projected to be available between 2028 and 2030. Many users express skepticism about the availability of new treatments, suggesting that relying on them is risky and that finasteride remains the most effective option.

The user tried pyrilutamide for hair loss and noticed reduced scalp itch and improved skin but stopped due to mild heart sensations. They plan to update after consistent use, noting improved sleep when applied at night.

The user reported significant hair improvement over 15 months using dutasteride, minoxidil (oral and topical), RU58841, ketoconazole, and microneedling. They are considering a hair transplant in 4-6 months.

Finasteride may be losing effectiveness for the user after 4.5 years, possibly due to intense workouts or a synchronized hair shedding cycle. Suggestions include switching to Dutasteride or continuing with Finasteride while considering a hair transplant for hairline density.

Placebo hair regrowth might be influenced by propylene glycol in lotions or participants lying about using other treatments like minoxidil, finasteride, or microneedling. Being part of a study can also improve hair health due to lifestyle changes.

The user has been taking oral dutasteride (DUT) and minoxidil (MIN) for 12 months, seeing some hair regrowth but questioning if it's typical for this timeframe. Suggestions include adding microneedling, topical minoxidil, or considering a hair transplant for further improvement.

A user experienced libido issues after using finasteride for five months, with elevated prolactin and estradiol levels. The discussion includes differing opinions on whether these symptoms are due to hormonal imbalances or post-finasteride syndrome.

The user is experiencing diffuse thinning and has started taking 0.5mg dutasteride and 5mg oral minoxidil daily, planning to wait a year before considering a hair transplant. They are advised to be patient, consult with doctors, and see how the medication affects their hair density before proceeding with surgery.

Dutasteride is considered superior for hair regrowth compared to finasteride, with many users reporting significant improvements. Some users experience side effects, but many find dutasteride effective when combined with minoxidil and other treatments.